ea0081p382 | Endocrine-Related Cancer | ECE2022
Vatseba Tamara
, Sokolova Liubov
, Pushkarev Volodymyr
, Pushkarev Viktor
, Kovzun Olena
, Tronko Mykola
Introduction: The increased risk of cancer in patients with diabetes mellitus (DM) creates an interest in finding mechanisms of the possible association of antidiabetic drugs and carcinogenesis. Metformin has the most documented evidence of pleiotropic oncoprotective effects, including increased stabilization of tumour suppressor p53, inhibition of NF-κB activation, slowing of the cell cycle and inhibition of mitosis due to decreased expression of cyclin D and cyclin E, a...